Open Interest and Volume Dynamics
On 7 January 2026, Apollo Hospitals (symbol: APOLLOHOSP) recorded an open interest (OI) of 44,633 contracts in its derivatives, marking a 10.08% increase from the previous OI of 40,545. This rise of 4,088 contracts is significant in the context of the stock’s recent trading activity. The volume for the day stood at 65,233 contracts, indicating robust participation from traders and investors alike.
The futures segment alone accounted for a value of approximately ₹38,002.9 lakhs, while the options segment exhibited an extraordinarily high notional value of ₹58,009.2 crores. The combined derivatives value reached ₹45,474.2 lakhs, underscoring the substantial liquidity and interest in Apollo’s contracts.
Price Performance and Market Context
Apollo Hospitals’ underlying stock price closed at ₹7,379, outperforming its hospital sector peers by 0.95% on the day. The stock has been on a positive trajectory, gaining 4.24% over the last two consecutive trading sessions. This momentum is supported by the stock trading above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains slightly below the 100-day moving average, indicating a generally bullish trend with some medium-term resistance.
Investor participation has also risen markedly, with delivery volumes on 6 January reaching 2.93 lakh shares, a 51.81% increase compared to the five-day average delivery volume. This surge in delivery volume suggests that investors are increasingly willing to hold the stock, reflecting confidence in its fundamentals and growth prospects.
Market Positioning and Directional Bets
The increase in open interest alongside rising volumes typically signals fresh positions being taken rather than existing ones being squared off. In Apollo’s case, the 10.08% jump in OI combined with a positive price move suggests that market participants are positioning for further upside. The futures and options data imply that traders are actively engaging in both directional and hedging strategies, with a bias towards bullishness given the stock’s recent outperformance.
Such positioning is consistent with Apollo Hospitals’ recent upgrade in its Mojo Grade from Hold to Buy as of 1 January 2026, reflecting improved fundamentals and market sentiment. The company’s Mojo Score stands at a healthy 71.0, reinforcing its status as a favourable investment within the hospital sector. The market cap grade of 1 further confirms its standing as a large-cap stock with strong institutional interest.
Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!
- - Long-term growth stock
- - Multi-quarter performance
- - Sustainable gains ahead
Liquidity and Trading Implications
Apollo Hospitals’ liquidity profile remains robust, with the stock’s traded value comfortably supporting trade sizes up to ₹4.67 crores based on 2% of the five-day average traded value. This liquidity ensures that institutional and retail investors can execute sizeable trades without significant market impact, a critical factor for derivatives traders looking to establish or unwind positions efficiently.
The stock’s one-day return of 0.33% contrasts favourably with the hospital sector’s decline of 0.45% and the Sensex’s marginal fall of 0.13%, highlighting Apollo’s relative strength amid broader market weakness. This outperformance is likely to attract further attention from momentum traders and long-term investors alike.
Technical and Fundamental Outlook
Technically, the stock’s position above multiple moving averages signals sustained buying interest and a positive trend. The slight lag below the 100-day moving average may act as a short-term resistance level, but the overall momentum remains constructive. The rising delivery volumes reinforce the conviction of investors holding the stock for the medium to long term.
Fundamentally, Apollo Hospitals continues to benefit from its leadership in the hospital sector, backed by a strong market capitalisation of ₹1,06,918 crores. The recent upgrade in Mojo Grade to Buy reflects improved earnings visibility, operational efficiencies, and favourable sector dynamics such as rising healthcare demand and increased medical infrastructure investments.
Want to dive deeper on Apollo Hospitals Enterprise Ltd.? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Investor Takeaway
The surge in open interest and volume in Apollo Hospitals’ derivatives signals a growing conviction among market participants about the stock’s near-term upside potential. Coupled with strong delivery volumes and positive price action, this suggests that investors are increasingly confident in the company’s fundamentals and sector outlook.
While the stock faces some resistance near the 100-day moving average, the overall technical and fundamental indicators remain supportive. Investors should monitor open interest trends and volume patterns closely, as sustained increases could herald further price appreciation. However, prudent risk management remains essential given the inherent volatility in derivatives markets.
In summary, Apollo Hospitals Enterprise Ltd. stands out as a compelling large-cap hospital sector stock with improving market sentiment, robust liquidity, and strong investor participation. The recent upgrade to a Buy rating and the positive momentum in derivatives activity reinforce its appeal for both short-term traders and long-term investors.
Unlock special upgrade rates for a limited period. Start Saving Now →
